Breast cancer stands as a primary malignancy among women, ranking second in global
cancer-related deaths. Despite treatment advancements, many patients progress to …

Currently licensed vaccine adjuvants offer limited mucosal immunity, which is needed to
better combat respiratory infections such as influenza. Mast cells (MCs) are emerging as a …

Hepatocellular carcinoma (HCC) is the fourth leading cause of malignancy worldwide, and
its progression is influenced by the immune microenvironment. Natural killer (NK) cells are …

Influenza outbreaks are a major burden worldwide annually. While seasonal vaccines do
provide protection against infection, they are limited in that they need to be updated every …

Breast cancer patients with estrogen receptor positive tumors face a constant risk of disease
recurrence for the remainder of their lives. Dormant tumor cells residing in tissues such as …